Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ruggeri

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Plos One|February 10, 2023
Casirivimab and imdevimab: Cost-effectiveness analysis of the treatment based on monoclonal antibodies on outpatients with Covid-19Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio
International Journal of Technology Assessment in Health Care|February 14, 2020
Estimating the fiscal impact of three vaccination strategies in ItalyMatteo Ruggeri, Eugenio Di Brino, Americo Cicchetti
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2013
Economic assessment of an anti-HCV screening program in ItalyMatteo Ruggeri, Silvia Coretti, Antonio Gasbarrini, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Clinical and economic benefits of a new paradigm of HCV diagnosis and treatmentStefano Fagiuoli, Matteo Ruggeri, Filipa Aragao, et al.
International Journal of Technology Assessment in Health Care|June 30, 2010
Extending influenza vaccination to individuals aged 50-64: a budget impact analysisAmerico Cicchetti, Matteo Ruggeri, Lara Gitto, et al.
Aging Clinical and Experimental Research|February 5, 2017
Preventing mobility disability in Europe: a health economics perspective from the SPRINTT studyNicolas Sirven, Thomas Rapp, Silvia Coretti, et al.
International Journal of Technology Assessment in Health Care|September 15, 2016
COST-EFFECTIVENESS ANALYSIS OF HERPES ZOSTER VACCINATION IN ITALIAN ELDERLY PERSONSSilvia Coretti, Paola Codella, Federica Romano, et al.
Pharmacoeconomics|February 29, 2020
Economic Evaluation of Treatments for Migraine: An Assessment of the Generalizability Following a Systematic ReviewMatteo Ruggeri, Carlo Drago, Francesco Rosiello, et al.
Blood Purification|August 30, 2014
Sevelamer is cost-saving vs. calcium carbonate in non-dialysis-dependent CKD patients in italy: a patient-level cost-effectiveness analysis of the INDEPENDENT studyMatteo Ruggeri, Filippo Cipriani, Antonio Bellasi, et al.
International Journal of Environmental Research and Public Health|October 29, 2020
Multi-Criteria-Decision-Analysis (MCDA) for the Horizon Scanning of Health Innovations an Application to COVID 19 EmergencyMatteo Ruggeri, Chiara Cadeddu, Paolo Roazzi, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Plos One|February 10, 2023
Casirivimab and imdevimab: Cost-effectiveness analysis of the treatment based on monoclonal antibodies on outpatients with Covid-19Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio
International Journal of Technology Assessment in Health Care|February 14, 2020
Estimating the fiscal impact of three vaccination strategies in ItalyMatteo Ruggeri, Eugenio Di Brino, Americo Cicchetti
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2013
Economic assessment of an anti-HCV screening program in ItalyMatteo Ruggeri, Silvia Coretti, Antonio Gasbarrini, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Clinical and economic benefits of a new paradigm of HCV diagnosis and treatmentStefano Fagiuoli, Matteo Ruggeri, Filipa Aragao, et al.
International Journal of Technology Assessment in Health Care|June 30, 2010
Extending influenza vaccination to individuals aged 50-64: a budget impact analysisAmerico Cicchetti, Matteo Ruggeri, Lara Gitto, et al.
Aging Clinical and Experimental Research|February 5, 2017
Preventing mobility disability in Europe: a health economics perspective from the SPRINTT studyNicolas Sirven, Thomas Rapp, Silvia Coretti, et al.
International Journal of Technology Assessment in Health Care|September 15, 2016
COST-EFFECTIVENESS ANALYSIS OF HERPES ZOSTER VACCINATION IN ITALIAN ELDERLY PERSONSSilvia Coretti, Paola Codella, Federica Romano, et al.
Pharmacoeconomics|February 29, 2020
Economic Evaluation of Treatments for Migraine: An Assessment of the Generalizability Following a Systematic ReviewMatteo Ruggeri, Carlo Drago, Francesco Rosiello, et al.
Blood Purification|August 30, 2014
Sevelamer is cost-saving vs. calcium carbonate in non-dialysis-dependent CKD patients in italy: a patient-level cost-effectiveness analysis of the INDEPENDENT studyMatteo Ruggeri, Filippo Cipriani, Antonio Bellasi, et al.
International Journal of Environmental Research and Public Health|October 29, 2020
Multi-Criteria-Decision-Analysis (MCDA) for the Horizon Scanning of Health Innovations an Application to COVID 19 EmergencyMatteo Ruggeri, Chiara Cadeddu, Paolo Roazzi, et al.
Pageof 6